Co-researcher Joe Chiba, Professor Emeritus of Tokyo University of Science, explains serum therapy for novel coronavirus infections in Nikkei Biotech.

Nikkei Biotech Article

Findings Reveal a Boost to Vaccine Development for New Coronas

To evaluate “inexpensive, quick-start” classical therapy (serum therapy) for new coronas.

Can Immune Memory of “Past Colds” Save the World from New Coronas?

Organoids Elucidate Mechanism of Multi-Organ Injury Caused by New Corona

Guest Researcher, National Institute of Infectious Diseases

Joe Chiba